Y-Logimed, the exclusive representative of Abbott Cardiovascular in Greece participated in the European Conference EuroPCR 2023 “The world-leading Course in interventional cardiovascular medicine” held in Paris, May 15-19.

The conference, which was attended by approximately 11,000 people and the largest multinational companies, hosted speakers for all over the world. During the conference, innovative technologies in Interventional Cardiology were presented with important educational activities for interventional cardiologists.

Abbott CardioVascular had major presence celebrating “20 Million XIENCE Stents Implants!!!!!”.

Y-Logimed exclusively offers the XIENCE product portfolio in the Greek market, improving the treatment and quality of life of thousands of patients throughout Greece.